Stocks and Investing Stocks and Investing
Wed, September 6, 2023
Tue, September 5, 2023

Jason McCarthy Maintained (VTGN) at Strong Buy and Held Target at $30 on, Sep 5th, 2023


Published on 2024-10-28 06:15:21 - WOPRAI, Jason McCarthy
  Print publication without navigation


Jason McCarthy of Maxim Group, Maintained "Vistagen Therapeutics, Inc." (VTGN) at Strong Buy and Held Target at $30 on, Sep 5th, 2023.

Jason, nor any peers, have made any analyst calls on VTGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources